The Global Use of Medicines - IMS Health

Global spending on pharmaceuticals
GLOBAL SPENDING ON MEDICINES
An accelerated shift in spending on generics is expected
An accelerated shift in spending on generics is expected
$605Bn
Spending
Spending by
by
Segment
Segment
$1,065-1,095Bn
$856Bn
2015
•!
•!
•!
•!
• Brands accounted for nearly two-thirds of
Brands accounted for nearly two-thirds of
global pharmaceutical spending in 2010
global pharmaceutical spending in 2010 but
but, as patents expire in developed
as patents expire in developed markets that
markets, that share is expected to decline.
share is expected to decline.
• Rapid growth in pharmerging markets is
Rapid largely growth from spending Pharmerging on generic markets drugs is
largely which from will spending contribute to on the generic rise in drugs the whic
contribute generic share to the of spending. rise the generic share of
spending.
• Global generic drug spending is estimated
Global to be generic $234Bn drug in 2010, spending up from is $124Bn estimated to
be $234Bn in 2005. in 2010, up from $124Bn in 2005
Generics • Generics spending in in 2015 is is expected to to be
between between $400-430Bn, $400-430Bn, 70% 70% of of which will be
outside will be developed outside developed markets. markets.
2005
2010
Source:
Source:
IMS Market
IMS
Prognosis,
Market
Apr
Prognosis,
2011
Apr 2011
The Global Use of Medicines: Outlook Through 2015
Report The by the Global IMS Institute Use for of Healthcare Medicines: Informatics Outlook Through 2015
Report by the IMS Institute for Healthcare Informatics
Chart notes
Spending in US$ with variable exchange rates.
Brand, Generic and Other segments defined by IMS’s
Chart Notes: proprietary market segmentation methodology which
Spending covers in US$ 31 leading with variable pharmaceutical exchange markets rates. globally.
Brand, Estimated Generic and global Other generic segments spending defined includes by estimates IMS’s of proprietary
Market unaudited Segmentation markets methodology, and market segments. which covers Estimates 31 ofleading
pharmaceutical Brand and markets Generic segments globally. in Estimated other markets global based generic on IMS
spending
Institute
includes
for Healthcare
estimates
Informatics
of unaudited
research.
markets
Brands
and market
segments.
include
Estimates
off-patent
of
brands.
Brand
Generics
and Generic
include
segments
branded
in other
markets based on IMS Institute for Healthcare Informatics
generics. Other includes OTC and non-categorized products.
research. Brands include off-patent brands. Generics include
branded generics. Other includes OTC and non-categorized
products.
6
6